Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Grossmont Center for Clinical Research
mi
from
La Mesa, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Grossmont Center for Clinical Research
mi
from
La Mesa, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Louisiana Research Center, LLC
mi
from
Shreveport, LA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Louisiana Research Center, LLC
mi
from
Shreveport, LA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Boston Clinical Trials, INC.
mi
from
Boston, MA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Boston Clinical Trials, INC.
mi
from
Boston, MA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Prism Research Inc.
mi
from
Saint Paul, MN
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Prism Research Inc.
mi
from
Saint Paul, MN
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
St Louis Center For Clinical Research
mi
from
Saint Louis, MO
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
St Louis Center For Clinical Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Asheville Gastroenterology Associates, P.A.
mi
from
Asheville, NC
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Asheville Gastroenterology Associates, P.A.
mi
from
Asheville, NC
Click here to add this to my saved trials
Effects of Alpha-1 Antagonist, Stress and Relaxation on Anorectal Functions
Effect of Stress and a Alpha-1 Antagonist on Anorectal Functions
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Effects of Alpha-1 Antagonist, Stress and Relaxation on Anorectal Functions
Effect of Stress and a Alpha-1 Antagonist on Anorectal Functions
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Augusta, KA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Augusta, KA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Dothan, AL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Dothan, AL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Gulf Shores, AL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Gulf Shores, AL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Huntsville, AL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Mobile, AL
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Mobile, AL
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Mesa, AZ
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Mesa, AZ
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Phoenix, AZ
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Tempe, AZ
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Tempe, AZ
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Tucson, AZ
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Hot Springs, AR
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Hot Springs, AR
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Little Rock, AR
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
North Little Rock, AR
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
North Little Rock, AR
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Anaheim, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Anaheim, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Carlsbad, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Carlsbad, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Cerritos, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Cerritos, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Chula Vista, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Chula Vista, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Encinitas, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Encinitas, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Fountain Valley, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Fresno, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Fresno, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Hawaiian Gardens, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Hawaiian Gardens, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Lancaster, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Lancaster, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Long Beach, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Los Angeles, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Los Angeles, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Mission Hills, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Mission Hills, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Murrieta, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Murrieta, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
North Hollywood, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
North Hollywood, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Pasadena, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Pasadena, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Poway, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Poway, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Sacramento, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
San Diego, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
San Diego, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
San Diego, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
San Diego, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
San Diego, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
San Diego, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
San Diego, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
San Diego, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Thousand Oaks, CA
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Colorado Springs, CO
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Colorado Springs, CO
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Denver, CO
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Denver, CO
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Denver, CO
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Denver, CO
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Denver, CO
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Denver, CO
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Littleton, CO
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Littleton, CO
Click here to add this to my saved trials
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated:  12/31/1969
Synergy Research Site
mi
from
Bristol, CT
12-Week Study of Plecanatide for CIC (The CIC3 Study)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Status: Enrolling
Updated: 12/31/1969
Synergy Research Site
mi
from
Bristol, CT
Click here to add this to my saved trials